medigraphic.com
ISSN 1816-8450 (Print)

2012, Number 2

<< Back Next >>

Geroinfo 2012; 7 (2)

Características clínico-epidemiológicas de la degeneración macular relacionada con la edad en un área de salud

Hernández BR, Triana CI, Carrasco GMR, Cid VB

Language: Spanish
References: 25
Page:
PDF size: 87.03 Kb.


ABSTRACT

The involute macular degeneration is important cause of visual disability in the elderly, Methods: Descriptive study and traverse in 230 older people of the area of health “Héroes de Girón” with diagnosis of this illness during the year 2007 with the objective of identifying the clinical and epidemic characteristics of the same one as cause of visual disability. The variable age, sex, color of the skin, civil state, occupation, academic level, personal and family systemic pathological antecedents, antecedents pathological family oculars, symptoms, corrected visual acuity and form clinic of the macular degeneration were analyzed. Results: prevailed the patients between 70 and 79 years (73,91%), the women (66,08%) and the white skin (65,21%). More than the half they were married or with stable relationships (56,52%), 62,61% was retired and 50,43% had primary level. Among the systemic personal antecedents the bone-muscle-joint dysfunctions prevailed (70,0%) and among the relatives, systemic and ocular, the arterial hypertension (80,43%) and the myopia (35,21%). The most frequent symptom was blurred vision (73,91%), 42,17% of the older people classified as weak visual moderate and in 49,77% the illness was in phase of maculophaty. Conclusions: The advanced age, the feminine sex and the white skin were the characteristics more represented in the studied sample, as well as the vascular illnesses, with hereditary bias and the lightest clinical forms of the macular degeneration with important visual repercussion.


REFERENCES

  1. GeriCuba. Red Cubana de Gerontología y Geriatría [sitio en Internet]. Cuba es ya un ejemplo de país en desarrollo con un envejecimiento importante [actualizado may 2007; citado may 2007]. Disponible en: http:www.sld.cu/sitios/gericuba/temas.php?idv=13176.

  2. Turlea C. New aspects in age related macular degeneration. Oftalmologia. 2012; 56(1):36-44.

  3. National Eye Institute. Vision problems in the US: prevalence of adult vision impairment and age-related eye disease in Americans. Maryland: Bethesda; 2002:56-62.

  4. Marticorena J, Gómez-Ulla F, Lago JR. Degeneración macular asociada a la edad. Madrid: Prous Science; 2005:29-31.

  5. Elmann MJ. Exudative age-related macular degeneration. En: Ryan SJ. Retina Vol. II. St. Louis: Mosby Company; 1989:175-200.

  6. Sedden JM. Epidemiology of age-related macular degeneration. En: Ryan SJ. Retina Vol. II. St. Louis: Mosby; 2001:1039,1065-9.

  7. Guides to Evaluation of Permanent Impairment 15th ed. The Visual System American Medical Association, 2001.

  8. Estándares Visuales. En: Vaughan D. Oftalmología General. México D.F.: El Manual Moderno; 2001: 487.

  9. Spalton DJ, Hitchings RA, Hunter PA. Atlas de Oftalmología clínica. Madrid: Harcourt; 1995:16.1-16.11.

  10. Araiz J. Estadios previos y degeneración macular relativa a la edad. Madrid: Prous Science; 2005:99.

  11. Friedman DS, O’Colain BJ, Muñoz B. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-72.

  12. López Astaburuaga JM. Degeneración macular relacionada con la edad. En: Afecciones retinales. Escuela de Medicina UDA, Chile Curso de Oftalmología; 2002.

  13. Jonasson F, Arnarsson A, Sasaki H, Peto T et al. The prevalence of age-related maculopathy in Iceland. Arch Ophthalmol 2002;120:379-85.

  14. Tasman W, Rovner B. Age-related macular degeneration. Treating the whole patient. Arch Ophthalmol 2004;122:168-9.

  15. Carrasco García M. Lograr una buena longevidad. La Habana: Editorial Científico-Técnica; 2005:53-82,143.

  16. Rocabruno Mederos JC. Tratado de Gerontología y Geriatría Clínicas. La Habana: Editorial Científico-Técnica; 1999:7-9,53-67,128-136.

  17. Álvarez Sintes R. Temas de Medicina General Integral. La Habana: ECIMED; 2001:66,195-196,303.

  18. Salva A, Vellar B, Albarede JC. Evaluación gerontológica. Primeros resultados de una unidad de evaluación geriátrica. Rev Gerontol 1994;4:179-4.

  19. Isas Cordové M, Triana Casado I, Torres Martín L, Pérez Rodríguez L, Seuc Martínez AH. Algunos aspectos clínico-epidemiológicos en el preoperatorio de la catarata senil. Rev Cub Oftalmol 2010;23(supl.1).

  20. Linares Fernández ME. Factores asociados a la prevalencia de hipertensión arterial en una población industrial. Rev Cub Salud y Trabajo 2001;1(1):23-6.

  21. Age-related macular degeneration: what you should know [monografía en Internet]. [actualizado ene 2007; citado jun 2007]. Disponible en: http://www.nei.nih.gov/health

  22. Bird A. Informe de la Reunión de Consenso del Fenotipo de la Degeneración Macular Relacionada con la Edad. Am J Ophthalmol 2007; 2(35):12.

  23. Walters G. Five year’s incidence of age-related maculopathy: the visual impairment project. Evidence-Based Ophthalmol 2004,5(4):210.

  24. Christoforidis JB, Tecce N, Dell'Omo R, Mastropasqua R, Verolino M, Costagliola C. Age related macular degeneration and visual disability. Curr Drug Targets. 2011 Feb;12(2):221-33.

  25. Siemsen DW, Brown WL. Vision rehabilitation of persons with age related macular degeneration. Semin Ophthalmol. 2011 May;26(3):65-8. doi: 10.3109/08820538.2010.527426.




2020     |     www.medigraphic.com